Holen Sie sich die Stockscreener-App
0.9793
1.25%
0.0121
Handel nachbörslich:
.99
0.0107
+1.09%
Adicet Bio Inc Aktie (ACET) Neueste Nachrichten
How sentiment analysis helps forecast Adicet Bio Inc.Quarterly Trade Report & Community Verified Swing Trade Signals - newser.com
Why Adicet Bio Inc. (1IJA) stock could rally strongly2025 Market Outlook & AI Driven Stock Movement Reports - newser.com
How strong is Adicet Bio Inc. stock revenue growth2025 Earnings Impact & Free Technical Pattern Based Buy Signals - newser.com
Orbimed advisors buys Adicet Bio (ACET) shares worth $5 million - Investing.com India
Orbimed advisors buys Adicet Bio (ACET) shares worth $5 million By Investing.com - Investing.com UK
What moving averages say about Adicet Bio Inc.2025 Price Targets & Entry Point Confirmation Alerts - newser.com
Multi factor analysis applied to Adicet Bio Inc.July 2025 Institutional & Real-Time Stock Movement Alerts - newser.com
Adicet Bio’s SWOT analysis: cell therapy stock faces pivotal moment By Investing.com - Investing.com Australia
What RSI levels show for Adicet Bio Inc. (1IJA) stockJuly 2025 Reactions & High Conviction Investment Ideas - newser.com
Guggenheim Maintains Adicet Bio (ACET) Buy Recommendation - Nasdaq
Adicet Bio’s SWOT analysis: cell therapy stock faces pivotal moment - Investing.com India
Adicet Bio (NASDAQ:ACET) Earns Sell (E+) Rating from Weiss Ratings - MarketBeat
Adicet Bio Inc Stock Analysis and ForecastBreakout Stock Watch & Grow Steadily With Our Wealth Roadmap - earlytimes.in
Adicet Bio stock holds steady as Citizens reiterates Market Perform - Investing.com
Adicet Bio reports positive results from ADI-001 autoimmune trial By Investing.com - Investing.com Canada
Adicet Bio Receives Nasdaq Extension for Compliance - TipRanks
Guggenheim raises Adicet Bio stock price target on positive lupus data - Investing.com
Adicet Bio Announces $80 Million Offering - citybiz
Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2 - Benzinga
Are Medical Stocks Lagging Exact Sciences (EXAS) This Year? - sharewise.com
Adicet Bio prices $80 million stock offering at $1 per share - Investing.com Nigeria
Adicet Bio reports positive results from ADI-001 autoimmune trial - Investing.com
Adicet Bio Announces Major Stock Offering Agreement - TipRanks
Adicet Bio Reports Promising Phase 1 Study Results - TipRanks
Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) - NewsBreak: Local News & Alerts
Adicet Bio, Inc. Announces $80 Million Registered Direct Offering - The Joplin Globe
70.0M shares: Adicet Bio Prices $80M Registered Direct Offering - Stock Titan
Adicet Bio, Inc. (NASDAQ:ACET) Receives $5.33 Consensus Target Price from Brokerages - Defense World
What analysts say about Adicet Bio Inc stockMid Cap Growth Trends & Free Explosive Portfolio Gains - earlytimes.in
Evaluating Adicet Bio Inc. with trendline analysisWeekly Trade Recap & Daily Profit Maximizing Tips - newser.com
Why Adicet Bio Inc. stock remains on buy listsMarket Activity Report & Reliable Volume Spike Alerts - newser.com
Can Adicet Bio Inc. (1IJA) stock reach $200 price targetQuarterly Portfolio Report & Expert Approved Momentum Ideas - newser.com
What to expect from Adicet Bio Inc. in the next 30 days2025 Historical Comparison & AI Forecasted Entry/Exit Points - newser.com
Adicet Bio, Inc. (NASDAQ:ACET) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Is Adicet Bio Inc a good long term investmentPrice Action Trading & High Profit Trading Alerts - earlytimes.in
What momentum shifts mean for Adicet Bio Inc.July 2025 Movers & Community Verified Swing Trade Signals - newser.com
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):